Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment.

Cardiometabolic risk factors in primary centred and rotator cuff-related shoulder osteoarthritis: a comparative study. RMD Open (2017) 0.75

Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy. J Neurol (2016) 0.75

Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06

Inflammation and atherosclerosis. Circulation (2002) 20.77

Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord (2003) 6.94

Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol (2004) 5.34

Role of oxidative stress in atherosclerosis. Am J Cardiol (2003) 3.66

Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol (1997) 1.86

Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry (1995) 1.65

Levodopa-induced dyskinesia: review, observations, and speculations. Neurology (1990) 1.22

Role of homocysteine in the development of cardiovascular disease. Nutr J (2015) 1.12

Limitations of current Parkinson's disease therapy. Ann Neurol (2003) 1.07

Association between serum homocysteine and arterial stiffness in elderly: a community-based study. J Geriatr Cardiol (2014) 1.00

Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol (2003) 0.99

Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol (2007) 0.98

Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about? Swiss Med Wkly (2006) 0.97

Prognostic value of left ventricular diastolic dysfunction in a general population. J Am Heart Assoc (2014) 0.96

Arterial stiffness as a risk factor for coronary artery disease. Curr Atheroscler Rep (2014) 0.95

Arterial stiffness. JRSM Cardiovasc Dis (2012) 0.93

Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology (2004) 0.93

The prognostic value of arterial stiffness in systolic heart failure. Cardiol J (2013) 0.89

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. Pharmacol Res (2011) 0.88

Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction. Arch Med Res (2007) 0.88

Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score-matched, longitudinal follow-up study. Am Heart J (2014) 0.86

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients. Expert Opin Drug Saf (2014) 0.84

Heart valve disease associated with treatment with ergot-derived dopamine agonists: a clinical and echocardiographic study of patients with Parkinson's disease. J Intern Med (2007) 0.82

An overview on the correlation of neurological disorders with cardiovascular disease. Saudi J Biol Sci (2014) 0.80

Vascular stiffness as a surrogate measure of mortality in patients with chronic kidney disease. J Hypertens (2014) 0.80

Family history of stroke is potentially associated with arterial stiffness in the Japanese population. Arch Cardiovasc Dis (2014) 0.80

Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking. Eur J Echocardiogr (2008) 0.79

Possible treatment concepts for the levodopa-related hyperhomocysteinemia. Cardiovasc Psychiatry Neurol (2009) 0.78

The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals. Nutrition (2013) 0.77

Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia. Clin Exp Hypertens (2013) 0.76

Influence of hyperhomocysteinemia on left ventricular diastolic function in Chinese patients with hypertension. Herz (2014) 0.76

Relation of neutrophil to lymphocyte ratio with the presence and severity of stable coronary artery disease. Clin Appl Thromb Hemost (2013) 0.85

Imaging behind occluded areas with an iatrogenic perforated balloon: A safe, practical, and simple new method of visualizing the distal lumen in total occlusion. J Interv Cardiol (2017) 0.75